“New Gene Tests Pose a Threat to Insurers,” by Gina Kolata, New York Times

“But for companies selling long-term care insurance, these tests could be a disaster, sending risky patients in search of policies even as those with fewer risks shy away, damaging an already fragile business. ‘There is a question about whether the industry is in a death spiral anyway,’ said Robert Hunter, director of insurance at the Consumer Federation of America. ‘This could make it worse.’”

LTC Comment (from Stephen A. Moses, President, Center for Long-Term Care Reform):
There is a simple solution to this dilemma. Allow LTCI carriers to make testing for the “Alzheimer’s gene” a condition of applying for coverage. That would create an incentive for people to apply before they take the test and it would protect the carrier, and its other insureds, from adverse selection.

New Gene Tests Pose a Threat to Insurers